Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia

Inclusion Criteria:

• Ability to confirm voluntary participation and agree to all trial purposes bysigning and dating the informed consent forms;

• Men aged 18 years or over and less than or equal to 60 years with a diagnosis ofAndrogenetic Alopecia grades IIIv to IV in the modified Norwood-Hamiltonclassification, who have been using minoxidil 5% for at least 3 months and willingto maintain the same style, approximate length and hair color throughout the test.

Exclusion Criteria:

• Known hypersensitivity to the formula components used during the clinical trial;

• History of alcohol and/or substance abuse within 2 years;

• Participants with other concomitant dermatological diseases on the scalp, except formild seborrhoea dermatitis;

• Participants with a history of surgical treatment for hair loss or shaved scalp;

• Participants who used shampoo or topical solution containing ketoconazole, tar,selenium, threonine or steroids in the last 2 weeks;

• Participants who used 5α reductase inhibitors, such as finasteride and dutasteride,in the last 12 months;

• Participants using testosterone replacement therapy (TRT) or usingtestosterone-containing gel;

• Participants who used micro-infusion of medications on the skin (MMP), microneedlingor intradermotherapy on the scalp in the last 3 months;

• Participants who have undergone radiation treatment for the scalp or chemotherapy inthe past year;

• Participants with diseases that can affect hair growth;

• Participants with a current medical history of cancer and / or cancer treatment inthe last 5 years;